Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04406012
Other study ID # Eskisehir University
Secondary ID Kirikkale Univer
Status Completed
Phase N/A
First received
Last updated
Start date February 16, 2016
Est. completion date July 1, 2016

Study information

Verified date September 2020
Source Eskisehir Osmangazi University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study is to investigate the analgesic effects of thoracal paravertebral block in the patients undergoing percutaneous nephrolitotomy. Paravertebral block was applied to the study group. Conventional analgesia methods were applied to the control group.


Description:

Randomization was divided into two groups by using closed envelope method. Postoperative pain scores at rest at 1, 2, 4, 6, 8, 10, 12, and 24 hours with VAS (0 = no pain, very severe pain = 10) using Visual Analogue Scale was made. VAS at rest and movement (coughing and taking a deep Breath) were evaluated. Patients with VAS> 4 received additional analgesics.


Recruitment information / eligibility

Status Completed
Enrollment 53
Est. completion date July 1, 2016
Est. primary completion date June 16, 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility ASA I, II, III patients aged 18-65 who consented to undergo unilateral percutaneous nephrolithotomy were eligible for the study. 53 patients were eligible and assesed.Informed consent was signed by all patients. Patients under 18 years of age, pregnant, with known hypersensitivity to local anesthetics, bleeding diathesis, depression and / or anxiety disorder, obesity (BMI> 35kg / m2), history of pneumothorax, phrenic nerve paralysis, severe aortic stenosis were excluded. Also who did not want to participate the study.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
paravertebral block
paravertebral block group

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
Eskisehir Osmangazi University Kirikkale University

Outcome

Type Measure Description Time frame Safety issue
Primary Patient VAS scores 0=no pain, 10=incredible pain 24 hours
Secondary Patient Satisfaction scores 0=not satisfied, 5=very good satisfied at the end of the 24 hours